{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:24:15Z","timestamp":1760300655995,"version":"3.41.0"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Since worldwide COVID-19 vaccination, <jats:sup>18<\/jats:sup>F-FDG uptake in reactive axillary lymph nodes has been frequently observed in PET\/CT studies. We describe a patient with breast cancer who underwent <jats:sup>18<\/jats:sup>F-FDG PET\/CT 7 days after receiving COVID-19 vaccination in the right thigh. <jats:sup>18<\/jats:sup>F-FDG uptake was observed in nonenlarged right-sided inguinal, iliac, and para-aortic lymph nodes. As the thigh can be used as an alternate site for COVID-19 vaccine injection in case of lymphedema in both arms or for adequate axillary staging in patients with breast cancer, physicians should be aware of such <jats:sup>18<\/jats:sup>F-FDG uptake pattern.<\/jats:p>","DOI":"10.1097\/rlu.0000000000003941","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T18:51:10Z","timestamp":1634755870000},"page":"275-276","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Subdiaphragmatic Lymph Nodes Uptake on 18F-FDG PET\/CT After COVID-19 Vaccination in the Thigh"],"prefix":"10.1097","volume":"47","author":[{"given":"Elske","family":"Quak","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adeline","family":"Morel","sequence":"additional","affiliation":[{"name":"Breast Cancer Unit, Department of Medical Oncology, Fran\u00e7ois Baclesse Comprehensive Cancer Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Faudemer","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christelle","family":"Levy","sequence":"additional","affiliation":[{"name":"Breast Cancer Unit, Department of Medical Oncology, Fran\u00e7ois Baclesse Comprehensive Cancer Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5181-8182","authenticated-orcid":false,"given":"Renaud","family":"Ciappuccini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,10,19]]},"reference":[{"journal-title":"Clin Nucl Med","article-title":"The challenge of staging breast cancer with PET\/CT in the era of COVID vaccination","year":"2021","key":"bib1-20250621"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1007\/s00259-021-05314-2","article-title":"Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA COVID-19 vaccine: incidence assessed by [(18)F]FDG PET-CT and relevance to study interpretation","volume":"48","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/RLU.0000000000003634","article-title":"COVID-19 vaccine-related local FDG uptake","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/RLU.0000000000003636","article-title":"FDG PET findings post-COVID vaccinations: signs of the times?","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"journal-title":"Clin Nucl Med","article-title":"False-positive axillary lymph nodes on FDG PET\/CT resulting from COVID-19 immunization","year":"2021","key":"bib5-20250621"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/RLU.0000000000003633","article-title":"18F-FDG-avid lymph nodes after COVID-19 vaccination on 18F-FDG PET\/CT","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/RLU.0000000000003597","article-title":"COVID-19 mRNA vaccination-induced lymphadenopathy mimics lymphoma progression on FDG PET\/CT","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"584","DOI":"10.2214\/AJR.21.25688","article-title":"Mitigating the impact of coronavirus disease (COVID-19) vaccinations on patients undergoing breast imaging examinations: a pragmatic approach","volume":"217","year":"2021","journal-title":"AJR Am J Roentgenol"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jacr.2021.03.001","article-title":"Unilateral lymphadenopathy after COVID-19 vaccination: a practical management plan for radiologists across specialties","volume":"18","year":"2021","journal-title":"J Am Coll Radiol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003941","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:06:41Z","timestamp":1750536401000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,19]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003941","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"type":"electronic","value":"1536-0229"},{"type":"print","value":"0363-9762"}],"subject":[],"published":{"date-parts":[[2021,10,19]]}}}